Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer. [electronic resource]
Producer: 19960221Description: 225-35 p. digitalISSN:- 1062-8401
- Aged
- Antibiotics, Antineoplastic -- therapeutic use
- Dactinomycin -- therapeutic use
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Prostatic Neoplasms -- drug therapy
- Receptors, Tumor Necrosis Factor -- drug effects
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.